Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived-but they can be improved.

Cancer biology & therapy

Volumn 2, Issue 4 Suppl 1, 2003, Pages

  Kerbel, Robert S ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ANIMAL; CANCER TRANSPLANTATION; CLINICAL TRIAL; DISEASE MODEL; HUMAN; METASTASIS; MOUSE; MOUSE MUTANT; NEOPLASM; REVIEW; TIME; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CLINICAL TRIALS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, SCID; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASMS; TIME FACTORS;

EID: 1542436704     PISSN: 15384047     EISSN: None     Source Type: Journal    
DOI: 10.4161/cbt.213     Document Type: Review

References (44)